Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Outcome of Acute Myeloid Leukemia in Adults Treated with Standard Chemotherapy-a Single Center Retrospective Study

Abdul Rashid Shah, Mohan Ram, Ahmad Alhuraiji, Anitha Kunhikrishnan, Rifat Jehan, Fatima Khadadah, Abdulaziz Hamadah, Salem Alshemmari, Talha Badar, Faran Naim, Samar Refaat, Rasha Galal Ghonema, Mahmoud Hasaneen, Dina Ismail Abdelrazik, Rasha Tawab, Ramesh Pandita

Blood (2023) 142 (Supplement 1): 5872.

https://doi.org/10.1182/blood-2023-189155

Published: 2023

Journal Articles

Adolescents and Young Adults with Multiple Myeloma, Kuwait Experience

Ahmad Alhuraiji, Rasha Galal Ghonema, Mahmoud Hasaneen, Mohan Ram, Salem Alshemmari, Fatima Khadadah, Abdulaziz Hamadah, Anitha Kunhikrishnan, Abdul Rashid Shah, Ramesh Pandita

Blood (2023) 142 (Supplement 1): 6641.

https://doi.org/10.1182/blood-2023-185015

Published: 2023

Journal Articles

Molecular Aberrations in Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome with Excess Blast II (MDS-EB II) in Kuwait

Ahmad Alhuraiji, Mohan Ram, Fatima M Khadadah, Anita Kunhikrishnan, Abdul Rashid Shah, Abdulaziz Hamadah, Salem Salem Alshemmari, Shakir Bahzad, Ramesh Pandita

Blood (2022) 140 (Supplement 1): 11795.

https://doi.org/10.1182/blood-2022-167898

Published: 2022

Journal Articles

Chronic Lymphocytic Leukemia with Deletion 13q: Prognostic Predictors and Outcome after Treatment with Fludarabine, Cyclophosphamide and Rituximab (FCR)

Abdul Rashid Shah, MD, Tariq Muzzafar, MBBS, Romana Asad, MD, Christine B Peterson, Hagop M. Kantarjian, MD, Alessandra Ferrajoli, MD, William G Wierda, MD PhD, Jan A. Burger, MD PhD, Nitin Jain, MD, Gautam Borthakur, MD, Maliha Khan, MD, Abhishek Chilkulwar, MD, Brion Randolph, MD, Lohith Gowda, MD, Michael J Keating

Blood (2017) 130 (Supplement 1): 5337.

https://doi.org/10.1182/blood.V130.Suppl_1.5337.5337

Published: 2017

Journal Articles

Life after Ponatinib Failure: Outcomes of Chronic and Accelerated Phase CML Patients Who Discontinued Ponatinib in the Salvage Setting

Prajwal Chaitanya Boddu, MD, Hagop M. Kantarjian, MD, Abdul Rashid Shah, MD, Gautam Borthakur, MD, Srdan Verstovsek, MD PhD, Guillermo Garcia-Manero, MD, Naval Daver, MD, Tapan Kadia, MD, Farhad Ravandi, MD, Nitin Jain, MD, Ahmad Alhuraiji, MD MRCP, Jan Burger, MD PhD, Steven M. Kornblau, MD, Sara Emogene Dellasala, BS, Sherry Pierce, BSN, BA, Elias J. Jabbour, MD, Jorge E. Cortes, MD

Blood (2016) 128 (22): 3073.

https://doi.org/10.1182/blood.V128.22.3073.3073

Published: 2016

NARROW

Outcome of Acute Myeloid Leukemia in Adults Treated with Standard Chemotherapy-a Single Center Retrospective Study

Adolescents and Young Adults with Multiple Myeloma, Kuwait Experience

Molecular Aberrations in Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome with Excess Blast II (MDS-EB II) in Kuwait

Chronic Lymphocytic Leukemia with Deletion 13q: Prognostic Predictors and Outcome after Treatment with Fludarabine, Cyclophosphamide and Rituximab (FCR)

Life after Ponatinib Failure: Outcomes of Chronic and Accelerated Phase CML Patients Who Discontinued Ponatinib in the Salvage Setting

Email alerts

ASH Publications

American Society of Hematology

Outcome of Acute Myeloid Leukemia in Adults Treated with Standard Chemotherapy-a Single Center Retrospective Study

Adolescents and Young Adults with Multiple Myeloma, Kuwait Experience

Molecular Aberrations in Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome with Excess Blast II (MDS-EB II) in Kuwait

Chronic Lymphocytic Leukemia with Deletion 13q: Prognostic Predictors and Outcome after Treatment with Fludarabine, Cyclophosphamide and Rituximab (FCR)

Life after Ponatinib Failure: Outcomes of Chronic and Accelerated Phase CML Patients Who Discontinued Ponatinib in the Salvage Setting

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only